Narratives of the convalescent plasma donor in a Peruvian social security hospital.: motivations, fears, expectations and experiences.
DOI:
https://doi.org/10.35434/rcmhnaaa.2022.154.1689Keywords:
Convalescent plasma, blood donors, COVID-19, Barriers to Access of Health Services , personal narrative, qualitative researchAbstract
Objectives: To know and explore from convalescent plasma donators' voices the experience in the blood donation process at a social security hospital. Material and Methods: Qualitative study with a phenomenological design. The investigation was carried out in 01 hospitals of the social security of Peru. Semi-structured interviews were carried out. Results: Eleven donors of convalescent plasma were interviewed. The main motivations for donating were being able to contribute to national research and supporting patients affected by COVID-19. Fears focus on the possible risk of contagion within the hospital. Donors emphasised the attention and support of health personnel alongside the donation procedure. The main expectations and suggestions point towards greater dissemination of donation campaigns with special emphasis on safety. Likewise, an improvement in the time of the donation procedure (from enrolment to the extraction of convalescent plasma), and the implementation of friendly spaces to encourage future blood donation campaigns were highlighted. Conclusions: The experience of the convalescent plasma donors was positive. However, improvements must be made in terms of processes and infrastructure to ensure future successful blood donation campaigns.
Downloads
Metrics
References
Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021;13(2):202. doi: 10.3390/v13020202
U.S. Food and Drug administration. Recommendations for Investigational COVID-19 Convalescent Plasma. [Internet]. United States: FDA; 2022 [citado 23 de noviembre de 2022]; Disponible en: https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-applications-inds-cber-regulated-products/recommendations-investigational-covid-19-convalescent-plasma
Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review. Cochrane Database Syst Rev [Internet]. 2021 [citado 19 de abril de 2022];(5). Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub4/appendices. doi: 0.1002/14651858.CD013600.pub2
Al‐Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kumaş LT, Sağdur L, et al. International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary. Vox Sanguinis. 2021;116(10):1117–35. doi: 10.1111/vox.13113
Fisher DL, Alin P, Malnick S. The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2. SN Compr Clin Med. 2021;3(3):790-2. doi: 10.1007/s42399-021-00827-1
Joyner MJ, Carter RE, Senefeld JW, Klassen SA, Mills JR, Johnson PW, et al. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021;384(11):1015-27. doi: 10.1056/NEJMoa2031893
Libster R, Pérez Marc G, Wappner D, Coviello S, Bianchi A, Braem V, et al. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med. 18 de febrero de 2021;384(7):610-8. doi: 10.1056/NEJMoa2033700
Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, et al. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021;96(5):1262-75. doi: 10.1016/j.mayocp.2021.02.008
Villanueva C, Neyra I, Sagastegui A, Chunga A, Oyanguren M, Guillermo-Roman M, et al. Efficacy and safety of convalescent plasma versus standard care in hospitalized patients with COVID-19 from the Peruvian Social Security Health System: open-label, randomized, controlled clinical trial. medRxiv. 2022;09. doi: https: 10.1101/2022.09.21.22280195
Alcalde-Rabanal JE, Lazo-González O, Nigenda G. [The health system of Peru]. Salud Publica Mex [Internet]. 2011 [citado 23 de noviembre de 2022];53 Suppl 2:s243-254. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000800019
Sanchez-Moreno F. [The national health system in Peru]. Rev Peru Med Exp Salud Publica [Internet]. 2014[citado 23 de noviembre de 2022];31(4). Disponible en: https://pubmed.ncbi.nlm.nih.gov/25597729/.
García Gutiérrez M, Sáenz de Tejada E, Cruz JR. Estudio de factores socioculturales relacionados con la donación voluntaria de sangre en las Américas. Rev Panam Salud Pública [Internet]. 2003 [citado 23 de noviembre de 2022];13:85-90. Disponible en: https://iris.paho.org/handle/10665.2/8408
Suministro de sangre para transfusiones en los países de América Latina y el Caribe 2016-2017 [Internet]. Estados unidos: Organización Panamericana de la Salud; 2020 [citado 23 de noviembre de 2022]. Disponible en: https://iris.paho.org/handle/10665.2/52150
Arias Quispe S, Moscoso Porras M, Matzumura Kasano J, Gutiérrez Crespo H, Pesantes MA. Experiencias y percepciones de los donantes de sangre sobre la donación en un hospital público de Perú. Horiz Méd Lima. 2018;18(3):30-6. doi: 10.24265/horizmed.2018.v18n3.06
Wittock N, Hustinx L, Bracke P, Buffel V. Who donates? Cross-country and periodical variation in blood donor demographics in Europe between 1994 and 2014. Transfusion (Paris). 2017;57(11):2619-28. doi: 10.1111/trf.14272
Ferguson E, Hill A, Lam M, Reynolds C, Davison K, Lawrence C, et al. A typology of blood donor motivations. Transfusion (Paris). 2020;60(9):2010-20. doi: 10.1111/trf.15913
Cimaroli K, Páez A, Newbold KB, Heddle NM. Individual and contextual determinants of blood donation frequency with a focus on clinic accessibility: a case study of Toronto, Canada. Health Place. marzo de 2012;18(2):424-33. doi: 10.1016/j.healthplace.2011.12.005
Prados Madrona D, Fernández Herrera MD, Prados Jiménez D, Gómez Giraldo S, Robles Campos R. Women as whole blood donors: offers, donations and deferrals in the province of Huelva, south-western Spain. Blood Transfus Trasfus Sangue. enero de 2014;12 Suppl 1(Suppl 1):s11-20. doi: 10.2450/2012.0117-12
Bani M, Giussani B. Gender differences in giving blood: a review of the literature. Blood Transfus Trasfus Sangue. octubre de 2010;8(4):278-87. doi: 10.2450/2010.0156-09
Stephanou AT, Moreira MC. Blood Donors’ Perception of Incentive Campaigns. Paid Ribeirão Preto. 2019;29:e2927. doi: 10.1590/1982-4327e2927
Wevers A, Wigboldus DHJ, Kort WLAM de, Baaren R van, Veldhuizen IJT. Characteristics of donors who do or do not return to give blood and barriers to their return. Blood Transfus. enero de 2014;12(Suppl 1):s37. doi: 10.2450/2013.0210-12
Javadzadeh H. Knowledge, attitude and practice of women about blood donation. Scientific Journal of Iran Blood Transfus Organ [Internet]. 2006 [cited 2023 Feb 1];3(3):213–9. Available from: https://bloodjournal.ir/browse.php?a_id=101&sid=1&slc_lang=en
Livitz IE, France CR, France JL, Fox KR, Ankawi B, Slepian PM, et al. An automated motivational interview promotes donation intention and self-efficacy among experienced whole blood donors. Wiley Online Library. 2019;59(9):2876–84. doi: 10.1111/trf.15402
Asamoah‐Akuoko L, Hassall OW, Bates I, Ullum H. Blood donors’ perceptions, motivators and deterrents in Sub-Saharan Africa – a scoping review of evidence. Br J Haematol. 2017;177(6):864-77. doi: 10.1111/bjh.14588
Mohammed S, Essel HB. Motivational factors for blood donation, potential barriers, and knowledge about blood donation in first-time and repeat blood donors. BMC Hematol. 2018;18(1):36. doi: 10.1186/s12878-018-0130-3
Sotgiu G, Dobler CC. Social stigma in the time of coronavirus disease 2019. Eur Respir J. 2020;56(2):2002461. doi: 10.1183/13993003.02461-2020
Abdelhafiz AS, Alorabi M. Social Stigma: The Hidden Threat of COVID-19. Front Public Health. 2020;8:429. doi: 10.3389/fpubh.2020.00429
Villa S, Jaramillo E, Mangioni D, Bandera A, Gori A, Raviglione MC. Stigma at the time of the COVID-19 pandemic. Clin Microbiol Infect. 2020;26(11):1450-2. doi: 10.1016/j.cmi.2020.08.001
Pajuelo MJ, Anticona Huaynate C, Correa M, Mayta Malpartida H, Ramal Asayag C, Seminario JR, et al. Delays in seeking and receiving health care services for pneumonia in children under five in the Peruvian Amazon: a mixed-methods study on caregivers’ perceptions. BMC Health Serv Res. 2018;18(1):149. doi: 10.1186/s12913-018-2950-z
Ypanaqué-Luyo P, Martins M. Uso de los servicios de salud ambulatorios en la población peruana. Rev. perú. med. exp. salud publica[Internet]. 2015 [Citado el 20 de enero del 2022];32(3):464–70. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342015000300008
García-Erce JA, Romón-Alonso Í, Jericó C, Domingo-Morera JM, Arroyo-Rodríguez JL, Sola-Lapeña C, et al. Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals. Int J Environ Res Public Health. 2021;18(7):3480. doi: 10.3390/ijerph18073480
Mahmasani LA, Hodroj MH, Finianos A, Taher A. COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications. Ann Hematol. 2021;100(5):1115. doi: 10.1007/s00277-021-04441-y
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Percy Soto Becerra, Silvana M. Matassini Eyzaguirre, Christian Villanueva Yapa, Ausberto Chunga Chunga, Arturo Sagastegui Soto, Ibeth Melania Neyra Vera, Suly Soto Ordoñez, Martina Guillermo Román, Martin Oyanguren Miranda, Percy Soto-Becerra, Leda Yamileé Hurtado Roca, Jorge L. Maguiña , Roger Vladimir Araujo-Castillo
This work is licensed under a Creative Commons Attribution 4.0 International License.
